Story perspectives

GLP-1 Medications Cut Alcohol Cravings in Obese Adults

10/22/2025

45 11

Summary

Story summary

A study of 20 adults with obesity found that glucagon-like peptide-1 (GLP-1) medications reduced alcohol cravings and intake.
Participants reported feeling less intoxicated and absorbed alcohol more slowly while taking GLP-1s.
Breath alcohol concentration was significantly lower in the GLP-1 group than in controls.
Researchers say GLP-1s may alter alcohol metabolism and could have implications for treating alcohol use disorders in the United States, pending further research.

1 of 1

Story summary

A study of 20 adults with obesity found that glucagon-like peptide-1 (GLP-1) medications reduced alcohol cravings and intake.
Participants reported feeling less intoxicated and absorbed alcohol more slowly while taking GLP-1s.
Breath alcohol concentration was significantly lower in the GLP-1 group than in controls.
Researchers say GLP-1s may alter alcohol metabolism and could have implications for treating alcohol use disorders in the United States, pending further research.